DART nanoparticle therapy: new treatment for triple-negative breast cancer

Researchers from University of Maryland School of Medicine (UMSOM; MD, USA) have developed a novel DART nanoparticle therapy for aggressive breast cancer that could be superior to the existing drug on the market.  Researchers from the UMSOM have developed a novel nanoparticle drug formulation that targets a specific receptor on triple-negative breast cancer cells. This treatment is reportedly more effective than the standard US FDA approved nanoparticle therapy currently available. In their recent article published in Science Advances and co-authored by others from the Translational Genomics Research Institute (AZ, USA) and Mayo Clinic Arizona (USA), the UMSOM team described their...